NYSEAMERICAN:CTEKCynergisTek Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CynergisTek Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $1.50 +0.05 (+3.45 %) (As of 06/2/2020 04:00 PM ET) Add Compare Share Today's Range$1.40Now: $1.50▼$1.5050-Day Range N/A52-Week Range$1.11Now: $1.50▼$4.93Volume54,459 shsAverage Volume23,852 shsMarket Capitalization$15.67 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Cynergistek, Inc. provides outsourced document solutions, IT consulting data security, and managed print services primarily to the healthcare industry in the United States. The company offers Incident Response, Vendor Security Management, and Patient Privacy Monitoring Service, as well as Compliance Assist Partner Program. It also serves financial institutions, and gaming and other industries. The company was formerly known as Auxilio, Inc. and changed its name to Cynergistek, Inc. in September 2017. Cynergistek, Inc. is based in Mission Viejo, California.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingCynergisTek has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.50, CynergisTek has a potential upside of 266.7% from its current price of $1.50.Amount of Analyst CoverageCynergisTek has only been the subject of 1 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesCynergisTek has received 149 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCynergisTek has received 154 “underperform” votes. (Add your “underperform” vote.)Community SentimentCynergisTek has received 50.83% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about CynergisTek and other stocks. Vote “Outperform” if you believe CTEK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CTEK will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCynergisTek does not currently pay a dividend.Dividend GrowthCynergisTek does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CynergisTek insiders have bought more of their company's stock than they have sold. Specifically, they have bought $24,575.00 in company stock and sold $0.00 in company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.3Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.75 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSEAMERICAN Industry Diversified Machinery Sub-IndustryN/A SectorIndustrial Products Current SymbolNYSEAMERICAN:CTEK Previous SymbolNYSEMKT:CTEK CUSIPN/A CIK1011432 Webwww.cynergistek.com Phone949-614-0700Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees292 Outstanding Shares10,449,000Market Cap$15.67 million Next Earnings Date8/11/2020 (Estimated) OptionableNot Optionable AMEX:CTEK Rates by TradingView Receive CTEK News and Ratings via Email Sign-up to receive the latest news and ratings for CTEK and its competitors with MarketBeat's FREE daily newsletter. CynergisTek (NYSEAMERICAN:CTEK) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of CynergisTek? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CynergisTek in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CynergisTek. When is CynergisTek's next earnings date? CynergisTek is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for CynergisTek. How were CynergisTek's earnings last quarter? CynergisTek Inc (NYSEAMERICAN:CTEK) announced its quarterly earnings results on Thursday, May, 14th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.17) by $0.01. The firm had revenue of $5.12 million for the quarter. View CynergisTek's earnings history. What price target have analysts set for CTEK? 2 brokerages have issued 1 year price targets for CynergisTek's stock. Their forecasts range from $4.00 to $7.00. On average, they anticipate CynergisTek's stock price to reach $5.50 in the next twelve months. This suggests a possible upside of 266.7% from the stock's current price. View analysts' price targets for CynergisTek. Has CynergisTek been receiving favorable news coverage? Press coverage about CTEK stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CynergisTek earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutCynergisTek. Are investors shorting CynergisTek? CynergisTek saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 29,200 shares, a decrease of 25.9% from the April 30th total of 39,400 shares. Based on an average daily trading volume, of 24,300 shares, the short-interest ratio is currently 1.2 days. Currently, 0.3% of the company's stock are short sold. View CynergisTek's Current Options Chain. Who are some of CynergisTek's key competitors? Some companies that are related to CynergisTek include Northbridge Industrial Services (NBI), Energy Technologies (EGY), Continental Materials (CUO), Xeros Technology Group (XSG), International Corona Capital (IC), Tricorn Group (TCN), Chamberlin (CMH), Associated British Engineering (ASBE) and Alstom (ALO). View all competitors. What other stocks do shareholders of CynergisTek own? Based on aggregate information from My MarketBeat watchlists, some companies that other CynergisTek investors own include AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), Genocea Biosciences (GNCA), Invesco (IVZ), SeaChange International (SEAC), SMTC (SMTX), Allena Pharmaceuticals (ALNA), Digi International (DGII), Ichor (ICHR) and Inovio Pharmaceuticals (INO). Who are CynergisTek's key executives? CynergisTek's management team includes the following people: Mr. Michael H. McMillan CISM, FHIMSS, CEO, Pres, Chief Strategy Officer & Director (Age 62)Mr. Paul T. Anthony, CFO, Corp. Sec. & Treasurer (Age 48)Mr. Bryan Flynn, Head of Investor RelationsMr. Jon Hilfiger, Sr. VP of Sales & MarketingMr. Jeremy Molnar, Sr. VP of Security Services What is CynergisTek's stock symbol? CynergisTek trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CTEK." Who are CynergisTek's major shareholders? CynergisTek's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Horton Capital Management LLC (9.19%), ARS Investment Partners LLC (2.09%) and Connors Investor Services Inc. (0.67%). Company insiders that own CynergisTek stock include Dana Davis Sellers, John D Abouchar, Judith Finger Krandel, Mark D Roberson, Paul Thomas Anthony, Robert Mccashin and William Caleb Barlow. View institutional ownership trends for CynergisTek. Which major investors are selling CynergisTek stock? CTEK stock was sold by a variety of institutional investors in the last quarter, including ARS Investment Partners LLC, and Connors Investor Services Inc.. View insider buying and selling activity for CynergisTek. Which major investors are buying CynergisTek stock? CTEK stock was acquired by a variety of institutional investors in the last quarter, including Horton Capital Management LLC. Company insiders that have bought CynergisTek stock in the last two years include Dana Davis Sellers, John D Abouchar, Judith Finger Krandel, Mark D Roberson, Paul Thomas Anthony, Robert Mccashin, and William Caleb Barlow. View insider buying and selling activity for CynergisTek. How do I buy shares of CynergisTek? Shares of CTEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is CynergisTek's stock price today? One share of CTEK stock can currently be purchased for approximately $1.50. How big of a company is CynergisTek? CynergisTek has a market capitalization of $15.67 million. CynergisTek employs 292 workers across the globe. What is CynergisTek's official website? The official website for CynergisTek is www.cynergistek.com. How can I contact CynergisTek? The company can be reached via phone at 949-614-0700. This page was last updated on 6/3/2020 by MarketBeat.com Staff
